SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor reports of a potential Japanese delegation visiting Greenland to evaluate rare earth opportunities, fueling hopes for strategic partnerships that could bypass Chinese supply chains. While the community remains divided on the pace of project development and communication, many shareholders are highlighting the stock's long-term potential as a critical component of Western defense and industrial supply independence.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing heightened activity and investor interest driven by persistent buyout rumors and significant trading volume, as the community debates whether the stock is undervalued given its product portfolio and cash position. Shareholders remain deeply divided, with some betting on a potential hostile takeover or acquisition while others express frustration over leadership and the stock's failure to maintain momentum.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors focus on the upcoming August PDUFA date and a key court hearing regarding distribution rights that could allow the company to pursue an independent US launch. The community is actively discussing the recent surge in short interest and the potential for a short squeeze, while debating how a favorable court ruling or FDA labeling outcome could expand the commercial value of their lead DMD therapy.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is experiencing high volatility as traders react to conflicting reports regarding the status of the Strait of Hormuz and ongoing U.S.-Iran negotiations. The community is deeply divided between those betting on a rapid supply-driven price crash following potential de-escalation and those anticipating further spikes due to persistent geopolitical instability and tight energy inventories.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is experiencing heightened volatility and a sharp pullback as investors weigh index rebalancing pressures and recent project delays against its long-term role as a key infrastructure provider for AI data centers. The community remains deeply divided, with some traders viewing the decline as a major buying opportunity while others express caution regarding the stock's valuation and the broader sustainability of the power-infrastructure trade.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is facing intense selling pressure as investors grapple with significant dilution concerns, negative sentiment regarding its debt obligations, and fears that the company's aggressive accumulation strategy has become a liability. While some community members are actively hunting for a bottom and viewing the volatility as a potential entry point for a long-term Bitcoin proxy, others are aggressively shorting the stock, labeling it a potential bankruptcy risk due to its complex financial structure and reliance on unsustainable dividend payments.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential inclusion in the Russell 1000 index, driving significant options activity and ongoing conflict between bullish sentiment and short sellers.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as retail investors weigh the recent loss of a key Medicare reimbursement court case against the company's strong revenue growth and upcoming clinical milestones. The community is actively debating whether the stock is undervalued or if potential institutional sell-offs and the impact of competing therapies will continue to weigh on the share price in the near term.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh strong operational fundamentals, such as expanded shipping agreements and infrastructure growth, against the persistent geopolitical instability in the Strait of Hormuz. While some community members remain focused on the potential for long-term cash flow from new contracts, active discussion is dominated by the volatility driven by conflicting headlines regarding U.S.-Iran diplomatic status and its subsequent impact on oil and gas supply chains.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is seeing increased social media chatter following the announcement of a new distribution deal with NBCUniversal, which restores access to key channels including Telemundo ahead of the FIFA World Cup. While bulls highlight this partnership and the company's integration within the Disney ecosystem as critical growth catalysts, bears remain skeptical, frequently citing the stock's long-term downward performance and management's past share sales as primary points of concern.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BofA Lifts PT on Credicorp (BAP) - Here's Why

BofA Lifts PT on Credicorp (BAP) - Here's Why...

Here's How Much $100 Invested In Credicorp 5 Years Ago Would Be Worth Today

Credicorp (NYSE:BAP) has outperformed the market over the past 5 years by 14.29% on an annualized basis producing an average annual return of 26.06%. Currently, Credicorp has a market capitalization of $30.23 billion.read more...

Credicorp (BAP) Upgraded to Buy: Here's What You Should Know

Credicorp (BAP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Credicorp (BAP) is a Great Momentum Stock: Should You Buy?

Does Credicorp (BAP) have what it takes to be a top stock pick for momentum investors? Let's find out.

Why Credicorp (BAP) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Credicorp (BAP) have what it takes? Let's find out.

Are Finance Stocks Lagging  Credicorp (BAP) This Year?

Here is how Credicorp (BAP) and American Tower (AMT) have performed compared to their sector so far this year.

Why Credicorp (BAP) is a Top Dividend Stock for Your Portfolio

BAP or CMWAY: Which Is the Better Value Stock Right Now?

BAP vs. CMWAY: Which Stock Is the Better Value Option?

Credicorp Q1 Earnings Call Highlights

Credicorp (BAP) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Credicorp Ltd. operates as a holding company, which engages in the provision of financial services. It operates through the following segments: Universal Banking; Microfinance; Insurance and Pensions; and Investment Banking and Wealth Management. The Universal Banking segment focuses on lending and investment services. The Microfinance segment consists of subsidiaries offering commercial banking activities and specialized financial services to support small and micro business clients. The Insurance and Pensions segment offers insurance products for property and casualty, life insurance business, and corporate health insurance and medical services. The Investment Banking and Wealth Management segment comprises of asset management, capital markets, corporate finance, and wealth management business units. The company was founded on August 17, 1995 and is headquartered in Lima, Peru.

Credicorp Ltd

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$6.77	--	--	N/A
Q1 '26	$6.90	$7.57	9.65%	BEAT
Q4 '25	$6.54	$5.80	-11.19%	MISSED
Q3 '25	$6.47	$6.50	0.40%	BEAT
Q2 '25	$5.98	$6.77	13.25%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

BAPCredicorp Ltd

Upcoming Earnings: Q2 '26

Historical Earnings

Latest BAP News